Anti-NMDA Receptor Encephalitis Clinical Pathway — Inpatient

Goals

  • Standardize the assessment of children with anti-NMDARE by an experienced team
  • Define treatment strategies for different facets of anti-NMDARE (psychiatric, autonomic, neurologic) and deploy these therapies consistently
  • Establish an organized immunomodulatory treatment algorithm with escalation to higher potency therapies

Metrics

  • Length of stay (hospital, ICU, rehabilitation)
  • Cognitive testing
    • % with testing at onset, discharge, 6 months, 12 months
    • Cognitive testing scores
    • Time to cognitive recovery
  • Rate of intubation, tracheostomy, G-tube, polypharmacy